Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-3-10
pubmed:abstractText
Mobile group II introns have been used to develop a novel class of gene targeting vectors, targetrons, which employ base pairing for DNA target recognition and can thus be programmed to insert into any desired target DNA. Here, we have developed a targetron containing a retrotransposition-activated selectable marker (RAM), which enables one-step bacterial gene disruption at near 100% efficiency after selection. The targetron can be generated via PCR without cloning, and after intron integration, the marker gene can be excised by recombination between flanking Flp recombinase sites, enabling multiple sequential disruptions. We also show that a RAM-targetron with randomized target site recognition sequences yields single insertions throughout the Escherichia coli genome, creating a gene knockout library. Analysis of the randomly selected insertion sites provides further insight into group II intron target site recognition rules. It also suggests that a subset of retrohoming events may occur by using a primer generated during DNA replication, and reveals a previously unsuspected bias for group II intron insertion near the chromosome replication origin. This insertional bias likely reflects at least in part the higher copy number of origin proximal genes, but interaction with the replication machinery or other features of DNA structure or packaging may also contribute.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-10716944, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-10903206, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-11046140, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-11274058, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-11278070, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-11371159, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-11731786, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-11917027, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-12453213, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-12571038, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-1697508, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-1846969, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-2540413, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-2548993, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-3033441, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-3526286, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-3530319, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-4866337, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-6286142, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-7585955, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-7664334, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-8692273, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-9118229, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-9278503, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-9362497, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-9620951, http://linkedlifedata.com/resource/pubmed/commentcorrection/12626707-9727488
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1362-4962
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1656-64
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Targeted and random bacterial gene disruption using a group II intron (targetron) vector containing a retrotransposition-activated selectable marker.
pubmed:affiliation
Institute for Cellular and Molecular Biology, Department of Chemistry and Biochemistry and Section of Molecular Genetics and Microbiology, School of Biological Sciences, University of Texas at Austin, Austin, TX 78712, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.